Image 1
Loxapine Capsule
Product Images NDC 0591-0372
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 0591-0372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Loxapine is a medication that comes in capsules and should be kept out of reach of children. The box has manufacturing information and instructions on how to store the medication between 20-25°C. The medication is manufactured by Actavis and comes in a bottle with 100 capsules. Each capsule contains 5 mg of the medication.*
Image 3
Each capsule of Loxapine Succinate contains 10 mg of Loxapine. The usual dosage information can be found in the insert. Loxapine Deponst capsules are manufactured by Watson Pharma Private Limited. It is important to keep the medication out of reach of children. Distribution is done by Actavis Inc. This medication is available only by prescription.*
Image 4
This is a medication description for Loxapine, a medication available in 25mg capsules, with the NDC code of 0591-0371-01. The capsule also contains the ingredient Lotapine Succinals. The dosage information is provided in the insert. The medication is manufactured by Actavis and should be kept out of children's reach.*
Image 5
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
